Moderna, Inc. (MRNA) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-05 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Mock James M CIK: 0001736359 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-05 | Code: M (Exercise of derivative) Shares: +11,798 Shares Owned After: 71,392 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [Transaction #2] Security: Common Stock Date: 2026-06-05 | Code: F (Payment of exercise/tax) Shares: -5,705 | Price: $51.59 Total Value: $294,320.95 Shares Owned After: 65,687 | Ownership: D (Direct) Footnotes: [F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-06-05 | Code: M (Exercise of derivative) Shares: -11,798 | Price: $0.00 Shares Owned After: 117,976 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [F3] 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. [F3] 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Footnotes (Complete Index) --- F1: Restricted stock units convert into common stock on a one-for-one basis. F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3: 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Signature --- /s/ /s/ James Dillon, As Attorney-in-Fact (2026-06-08)